Today: 10 June 2026
Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites
23 January 2026
1 min read

Intel stock sinks in premarket after weak outlook; AI data-center supply crunch bites

New York, Jan 23, 2026, 06:07 (EST) — Premarket

  • Intel shares dropped roughly 12% in premarket trading following a weak Q1 forecast
  • As AI data-center demand spikes, investors turn back to supply constraints
  • Traders are focused on the open, with big-tech earnings due next week and the Fed meeting looming for fresh clues

Intel (INTC.O) shares tumbled about 12% in premarket trading Friday after the chipmaker’s forecast missed expectations, pulling back from a recent surge. If the decline sticks, Intel would lose roughly $31 billion in market value. Bernstein analysts slammed the outlook, saying the company “woefully misjudged” the server cycle. Reuters

The warning is significant because Intel has turned into a crowded turnaround play. Investors are betting heavily on AI data-center expansions boosting demand for the older, high-volume chips that still operate alongside the newest AI accelerators.

Intel forecasted first-quarter revenue between $11.7 billion and $12.7 billion, with non-GAAP earnings per share hitting $0.00—this excludes certain one-time items. CEO Lip-Bu Tan said the company is “working aggressively to grow supply” to meet demand. CFO David Zinsner added that available supply will be tightest in Q1 but should improve in Q2 and beyond. Intel Corporation

But all attention was on what Intel can’t deliver right now. The company forecast revenue and profit below what analysts expected and admitted it has struggled to meet demand for server central processors — CPUs that run alongside Nvidia’s GPUs in AI data centers. “In the short term, I’m disappointed that we are not able to fully meet the demand in our markets,” Tan told analysts. Zinsner added that customers were “a little bit caught off guard” by how quickly demand surged. Reuters

Uncertainty clouds Intel’s foundry ambitions as it aims to carve out a contract chipmaking business to compete with larger players. The Financial Times highlighted investor worries over production expenses and delays in Intel’s next manufacturing phases. Despite generating billions in quarterly revenue, the foundry unit continues to run at a loss.

Some bulls highlight the recent quarter. Barron’s reported that Intel beat estimates for the December period but rattled investors with a cautious outlook for the first quarter. Meanwhile, Zinsner cautioned that supply constraints might linger and higher memory-chip prices could weigh on results later this year.

The downside is glaring. Intel faces the risk of missing out on lucrative data-center sales if it can’t ramp up production swiftly. That would drag out its turnaround timeline, particularly if customers divert their spending to other chips or if rising component costs continue to weigh on the PC market.

After Intel’s earnings, all eyes shift to the buyers. Investors will scrutinize next week’s big tech earnings for hints on data-center budgets, which are key to server-chip demand.

Macro factors continue to weigh on rate-sensitive tech stocks as investors look ahead to the Federal Reserve’s upcoming policy meeting on Jan. 27–28.

Stock Market Today

  • Is SpaceX Stock Worth $135 a Share? Experts Weigh In on Potential IPO
    June 10, 2026, 7:49 AM EDT. SpaceX, the private aerospace manufacturer, faces questions about its valuation ahead of a potential initial public offering (IPO) at a $135 per share target price. Experts debate whether the figure reflects realistic growth or overestimates future prospects. SpaceX claims it is constrained only by the "laws of physics," highlighting its technological edge. Investors are assessing if the share price accounts adequately for risks related to market competition, regulatory hurdles, and the high capital demands of space ventures. The market awaits clearer signals on SpaceX's financials to gauge the wisdom of investing at this valuation.

Latest articles

Archer Aviation Stock Falls After ARK Sale as ACHR Bulls Face Fresh eVTOL Test

Archer Aviation Stock Falls After ARK Sale as ACHR Bulls Face Fresh eVTOL Test

10 June 2026
Archer Aviation plunged 7.16% to $5.32 after ARK Invest dumped over 2.2 million shares across three ETFs, intensifying pressure on a stock already sensitive to funding and FAA certification risks; shares traded at $5.19 premarket as investors weighed cash burn, ongoing losses, and the urgent need for operational milestones before capital runs thin.
Tesla Drops Pre-Market as SpaceX IPO Buzz Puts Pressure on Musk Plays

Tesla Drops Pre-Market as SpaceX IPO Buzz Puts Pressure on Musk Plays

10 June 2026
Tesla slid 3% to $396.68 Tuesday and dropped another 1.26% premarket as SpaceX’s record $75 billion IPO, with over $250 billion in demand, gives investors a new Musk-linked bet, raising fears capital will rotate out of Tesla and other high-growth tech stocks just as Tesla’s next phase relies on heavy AI and robotaxi spending.
Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

Coupang (CPNG) Gains Ahead of South Korea Privacy Fine Ruling

10 June 2026
Coupang shares jumped 4.68% to $15.90 as investors await a South Korean privacy ruling that could fine the company up to 1.36 trillion won over a breach affecting 33 million records; the commission’s decision, expected as soon as Thursday, will determine the true financial impact and next move for the stock.
Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

Apple Shares Slip After WWDC, Siri AI Plans Leave Upgrade Path Unclear

10 June 2026
Apple shares fell $11.01 to $290.55 after WWDC as investors reacted to Siri AI’s delayed, English-only beta launch, strict device limits, and lack of immediate iPhone demand boost, with Morgan Stanley warning over 1.3 billion iPhones can’t access advanced features and regional rollout hurdles in the EU and China raising doubts about a global upgrade cycle.
CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing
Previous Story

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

Brent crude price rebounds toward $65 on Trump Iran warning and Kazakhstan outage
Next Story

Brent crude price rebounds toward $65 on Trump Iran warning and Kazakhstan outage

Go toTop